Evidence map›Paper›PMID 41630773›Full record

ArticleOpen veterinary journal2025

Potential of secondary metabolite compounds of sweet potato (

Pramu Pramu, Raden Wisnu Nurcahyo, Joko Prastowo, Irkham Widiyono

Abstract read
In one paragraph

Article in Open veterinary journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Pramu PramuYogyakarta Magelang Agricultural Development Polytechnic, Magelang, Indonesia.
Raden Wisnu NurcahyoDepartment of Parasitology, Faculty of Veterinary Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Joko PrastowoDepartment of Parasitology, Faculty of Veterinary Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Irkham WidiyonoDepartment of Internal Medicine, Faculty of Veterinary Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia.

Funding

BPPSDMP Scholarship Research Fund, Indonesian Ministry of Agriculture
6 · The paper itself

Abstract

Background: Gastrointestinal nematodes are a major impediment to the health and productivity of small ruminants. Studies have examined the effects of anthelmintic resistance and herbal medicines on sheep and goat farms. Sweet potato ( Aim: This study aimed to assess the potential of sweet potato leaves as a natural anthelmintic by quantifying the concentrations of secondary metabolites in mountainous and coastal areas. In vitro studies were conducted to examine the effects of sweet potato leaf aqueous extract (A.E.I.) on the viability of Methods: Sweet potato leaves were collected from two sites. The leaves were selected, washed, and dried. The total flavonoid, saponin, tannin, alkaloid, and steroid concentrations were analyzed using UV-Vis spectrophotometry Results: Variations in secondary metabolite concentrations were observed in cultivated areas in coastal and mountainous regions. Sweet potato leaves from the mountains have higher levels of flavonoids, alkaloids, tannins, and saponins than those from coastal areas. In contrast, coastal plants have higher levels of steroids. An Conclusion: Sweet potato plants grown in mountainous and coastal areas have varying levels of phytochemical compounds known to have anthelmintic effects, including flavonoids, alkaloids, tannins, saponins, and steroids. A.E.I. exhibited anthelmintic effects against

Indexed as

AnthelminticsHaemonchusIpomoea batatasPlant ExtractsAlkaloidsAnimalsFemaleFlavonoidsPlant LeavesAlkaloidsAnthelminticsFlavonoidsPlant ExtractsAnthelminticAqueous extractIn vitroIpomoea batatasSecondary metabolites

Identifiers

PMID41630773
PMCPMC12861473

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.